                         SEQUENCE LISTING

<110>  OXFORD NANOPORE TECHNOLOGIES PLC
 
<120>  METHODS FOR COMPLEMENT STRAND SEQUENCING

<130>  N424437WO

<150>  US 63/190,689
<151>  2021-05-19

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Octyl-Tocopherol]-8888, wherein 8 is iSp18 spacer

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  3'-Cy5

<400>  1
ttgaccgctc gcctc                                                        15


<210>  2
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Chol]-8888, wherein 8 is iSp18 spacer

<400>  2
ttgaccgctc gcctc                                                        15


<210>  3
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Octyl-Tocopherol]-33, wherein 3 is iSp3 spacer

<400>  3
ttgaccgctc gcctc                                                        15


<210>  4
<211>  81
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-333399, wherein 3 is iSpC3 and 9 is iSp9

<220>
<221>  misc_feature
<222>  (24)..(25)
<223>  iSpC3

<220>
<221>  misc_feature
<222>  (47)..(48)
<223>  333, wherein 3 is iSpC3

<220>
<221>  misc_feature
<222>  (50)..(50)
<223>  2'-O-Methyl RNA

<220>
<221>  misc_feature
<222>  (51)..(51)
<223>  2'-O-Methyl RNA

<220>
<221>  misc_feature
<222>  (53)..(54)
<223>  iSp18

<220>
<221>  misc_feature
<222>  (81)..(81)
<223>  3'-amino C7 labelled with azidohexanoic acid

<400>  4
cttatttttt tattttttta ttttctacat ctccttattc gctgcacttu uttcctgtac       60

ttcgttcagt tacgtattgc t                                                 81


<210>  5
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-33333333, wherein 3 is iSpC3 spacer

<400>  5
tttttttttt tttttttttt tttt                                              24


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Octyl-Tocopherol]-8, wherein 8 is iSp18 spacer

<400>  6
gtcaggatta gtgcgtctac atggc                                             25


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Octyl-Tocopherol]-8, wherein 8 is iSp18 spacer

<400>  7
gtcaggatta gtgcgtctac a                                                 21


<210>  8
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Octyl-Tocopherol]-8, wherein 8 is iSp18 spacer

<400>  8
gtcaggatta gtgcgt                                                       16


<210>  9
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  5'-[Octyl-Tocopherol]-8, wherein 8 is iSp18 spacer

<400>  9
gtcaggatta gt                                                           12


